نتائج البحث 431-440 من 21502 لعملية البحث عن Two-phase
Phase 1/2 Study Of MRTX1719 In Solid Tumors With MTAP Deletion. Rochester, Minn., Jacksonville, Fla., Scottsdale/Phoenix, Ariz. The purpose of this study is ...
In the phase II part, to evaluate the preliminary antitumor activity of two different doses/regimens of [177Lu]Lu-NeoB in combination with capecitabine ...
Phase 2 Study with TTI-622 and TTI-621 in Relapsed Diffuse Large B-Cell Lymphoma (DLBCL). Rochester, Minn. The purpose of ths study is to find out more about ...
The purpose of phase 2 of this trial is to evaluate the effectiveness of sequentially administering temozolomide and selinexor in recurrent glioblastoma as ...
Study B9991011 is a multi-center, international, randomized, open label, 2 component (Phase 1b followed by Phase 3), parallel-arm study of avelumab in ...
... stage IV metastatic melanoma. A Registry Called Every Child for ... This is an open-label, two-part Phase 2 study investigating CGT9486 for the ...
The purpose of this study is to determine the maximum tolerated dose (MTD) and/or the recommended Phase 2 dose (RP2D) of WSD0922-FU in subjects with ...
... phase. Defining the Immunologic Profile of Sentinel Lymph Nodes and ... two prior lines of therapies. The study has 2 Modules: Module 1 for FL and Module 2 for ...
Study B9991011 is a multi-center, international, randomized, open label, 2 component (Phase ... Most newly-diagnosed CLL patients have early-stage disease at the ...
ABBV-383 is an investigational drug being developed for the treatment of R/R Multiple Myeloma (MM). This study includes 2 parts; step-up dose optimization (Part ...
لا تُقدم Mayo Clinic الدعم للشركات أو المنتجات المُعلَّن عنها هنا. لكن تدعم العائدات الإعلانية رسالتنا غير الربحية.
تحقق من هذه الكتب الأكثر مبيعًا والعروض الخاصة على الكتب والنشرات الإخبارية من Mayo Clinic Press.
تساهم التبرّعات، وهي قابلة للخصم الضريبي، في دعم آخر التطورات في الأبحاث وطرق الرعاية لإحداث نقلة نوعية في الطب.